Medical Communications

Norton Rose Fulbright’s Dominic Stuttaford, James Baillieu and Susie Brain discuss the implications regarding the recent reforms to cross-border royalties.The …

BenevolentAI, a London based drug discovery biotech, has revealed that a $115 million financing round now sees the company valued …

Dr John Tsai has been welcomed to the fold as Novartis’ new Head of Global Development and Chief Medical Officer, …

The first stage of separation for the EMA from the UK came with the decision to relocate its headquarters to …

Immunomedics hasn’t had the most straight forward year, its $2 billion deal with Seattle Genetics was scuppered by activist investors, …

Frequency Therapeutics is a biotech with big ideas and it has made a big appointment to back up those ideas, …

After a busy start to the year, with a number of acquisitions and a few divestments, Sanofi’s Chief Financial Officer, …

Frequency Therapeutics is a biotech with big ideas and it has made a big appointment to back up those ideas, …

When it comes to the pharmaceutical supply chain, patient safety has and will always be a primary concern for all …

We’re excited to share with you our recently redesigned homepage, at the same site address: DIAglobal.org. The main objectives of …

PrimeVigilance will be exhibiting and celebrating its 10th anniversary at #DIAEurope2018, raffling 10 bottles of champagne away! Stop by their …

It’s Friday the 13th, but that doesn’t change a strong showing from the industry this week as it continued to …

South Korea’s Hanmi Pharmaceutical has announced its intention to terminate development of its lung cancer drug Olita (olmutinib) as it …

A massive effort funded by Cancer Research UK has been able to track the different evolutionary pathways of kidney cancer …

Eisai has teamed up with the Broad Institute, the Mycobacteria Research Laboratories at Colorado State University and the University of …